logo-loader

Suda in an ASX trading halt

Published: 14:00 24 Jan 2017 AEDT

ASX-Exchange-square-757
Suda has been granted a trading halt

Details are pending in relation to a settlement with HC Berlin Pharma, a German company listed on the Frankfurt Stock Exchange.

The halt will remain in place until the opening of trade on Friday, 27th January 2017, or earlier if an announcement is made to the market.

Arovella Therapeutics to enhance solid tumour pipeline with exclusive...

Arovella Therapeutics Ltd (ASX:ALA) CEO Michael Baker joins Jonathan Jackson in the Proactive studio to discuss a new, exclusive licensing agreement signed with the University of North Carolina Lineberger Comprehensive Cancer Center to incorporate a novel armouring cytokine technology (IL-12-TM)...

on 5/2/24